Functional expression and comparative characterization of four feline P450 cytochromes using fluorescent substrates

Posaconazole Pharmacokinetics in Healthy Cats after Oral and Intravenous Administration

(2016) D.I. Mawby et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Characterization of feline cytochrome P450 2B6

(2016) Gaku Okamatsu et al.   XENOBIOTICA

Possible drug–drug interaction in dogs and cats resulted from alteration in drug metabolism: A mini review

(2015) Kazuaki Sasaki et al.   Journal of Advanced Research

Identification and functional characterization of novel feline cytochrome P450 2A

(2014) Gaku Okamatsu et al.   XENOBIOTICA

Time-dependent inhibition of CYP3A4 by sertraline, a selective serotonin reuptake inhibitor

(2013) Yasuhiro Masubuchi et al.   BIOPHARMACEUTICS & DRUG DISPOSITION

Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics

(2013) Marilyn N. Martinez et al.   DRUG METABOLISM REVIEWS

Feline Drug Metabolism and Disposition

(2013) Michael H. Court   VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE

Mass Spectrometry-Based Quantification of CYP Enzymes to Establish In Vitro/In Vivo Scaling Factors for Intestinal and Hepatic Metabolism in Beagle Dog

(2012) Aki T. Heikkinen et al.   PHARMACEUTICAL RESEARCH

The Proton Pump Inhibitor, Omeprazole, but Not Lansoprazole or Pantoprazole, Is a Metabolism-Dependent Inhibitor of CYP2C19: Implications for Coadministration with Clopidogrel

(2011) B. W. Ogilvie et al.   DRUG METABOLISM AND DISPOSITION

Expression of Two Novel Cytochrome P450 3A131 and 3A132 in Liver and Small Intestine of Domestic Cats

(2011) Kouichi HONDA et al.   JOURNAL OF VETERINARY MEDICAL SCIENCE

Expression and Characterization of Dog Cytochrome P450 2A13 and 2A25 in Baculovirus-Infected Insect Cells

(2010) D. Zhou et al.   DRUG METABOLISM AND DISPOSITION

Molecular Cloning and Expression of Cytochrome P450 2D6 in the Livers of Domestic Cats

(2010) Tetsuya KOMATSU et al.   JOURNAL OF VETERINARY MEDICAL SCIENCE

Cytochrome P450-mediated hepatic metabolism of new fluorescent substrates in cats and dogs

(2010) C. D. Van BEUSEKOM et al.   JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS

Insights into the Substrate Specificity, Inhibitors, Regulation, and Polymorphisms and the Clinical Impact of Human Cytochrome P450 1A2

(2009) Shu-Feng Zhou et al.   AAPS Journal

Human CYP2E1 is regulated by miR-378

(2009) Takuya Mohri et al.   BIOCHEMICAL PHARMACOLOGY

Canine CYP2B11 metabolizes and is inhibited by anesthetic agents often co-administered in dogs

(2009) M. T. BARATTA et al.   JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS

Evaluation of Escherichia coli Membrane Preparations of Canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with Coexpressed Canine Cytochrome P450 Reductase

(2008) C. W. Locuson et al.   DRUG METABOLISM AND DISPOSITION

Functional Expression and Comparative Characterization of Nine Murine Cytochromes P450 by Fluorescent Inhibition Screening

(2008) L. A. McLaughlin et al.   DRUG METABOLISM AND DISPOSITION

Differential expression ofCYP3A12andCYP3A26mRNAs in canine liver and intestine

(2008) K. L. Mealey et al.   XENOBIOTICA